	Supervised Multimodal Prehabilitation and Clinical Outcomes in Older Patients With Frailty and Gastric Cancer: The GISSG+2201 Randomized Clinical Trial. JAMA Surg Sun Y, Tian Y, Cao S, Li L, Yu W, Ding Y, Wang X, Kong Y, Wang X, Wang H, Hui X, Qu J, Wang H, Duan Q, Yang D, Zhang H, Zhou S, Liu X, Li Z, Liu Q, Zhou Y. PMID: 41604182 [PubMed - as supplied by publisher]
	Family-Centered Advance Care Planning in Patients With Breast Cancer: A Randomized Controlled Trial in China. Omega (Westport) Wang R, Gao R, Pei S, Zhang C, Li D, Shen Y. PMID: 41604160 [PubMed - as supplied by publisher]
	Deep-Learning Serial CT Prediction of Survival in Immunotherapy-Treated Non-Small Cell Lung Cancer. JAMA Netw Open Sako C, Kurland BF, Schmidt TG, He J, De Groot M, Patel AA, Owen DH, Amini A, Curti BD, Kelly RJ, Page RD, Swalduz A, Beregi JP, Chrusciel J, Sanchez S, Weiss J, Liu A, Gevaert O, Hart A, Simon GR, Parikh RB, van der Aart J, Jordan P. PMID: 41604152 [PubMed - in process]
	Two decades of artificial intelligence in colon cancer diagnosis and treatment: a bibliometric analysis of research trends (2003-2023). Updates Surg Wu CY, Zhong WJ, Wu SJ, Ye K. PMID: 41604135 [PubMed - as supplied by publisher]
	Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody-drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology. Clin Transl Oncol Majem M, Molina Mata K, Mayor Ibarguren A, Zafra Poves M, Requena C, Aparisi Aparisi FA, Carrera C, Blasco Cordellat A, Freites-Martinez A, Sanmartin O. PMID: 41604110 [PubMed - as supplied by publisher]
	MicroRNA-mediated modulation of cancer-associated fibroblasts in HER2-positive breast tumor microenvironment: a comprehensive review. Discov Oncol Ardah MT, Abdulsahib WK, Naji HA, Jyothi SR, Sahoo S, Janney JB, Sharma V, Sinha A, Kholiyeva M. PMID: 41604098 [PubMed - as supplied by publisher]
	Cell death and immune escape in the tumor microenvironment: associated mechanisms, opportunities and challenges. Apoptosis Guo J, Liu Y, Huang Y, Liu X, Hu Y. PMID: 41604068 [PubMed - in process]
	(18)F-FDG PET radiomics model for predicting TARE response in patients with colorectal cancer liver metastases. Jpn J Radiol Topcuoglu OM, Tuncer O, Oral M, Gormez A, Toklu T, Selcuk NA. PMID: 41604060 [PubMed - as supplied by publisher]
	Methodological and reporting considerations in real-world anamarin studies of gastric cancer-related cachexia. Gastric Cancer He Y, Tian G. PMID: 41604052 [PubMed - as supplied by publisher]
	The role of microRNAs in modulating Wnt signaling pathway dynamics and their therapeutic implications in non-small cell lung cancer. Discov Oncol Wang Y, Yarmukhamedova S, Alkhamessi RN, Kadham MJ, Aboqader RF, Thakur V, Naser RH, Lakshmaiya N, Jayapal P, Almagharbeh WT, Sârbu I, Aditya FA, Ciongradi CI, Hamzehzadeh S. PMID: 41604020 [PubMed - as supplied by publisher]
	Post-traumatic growth related to long-term follow up in survivors of childhood cancer: a national qualitative study. Support Care Cancer Mendonça K, Hou SHJ, Wright H, Henry B, Drummond R, Forbes C, Rahamatullah I, Duong J, Erker C, Taccone MS, Sutherland L, Nathan PC, Spavor M, Goddard K, Reynolds K, Schulte FSM. PMID: 41604003 [PubMed - in process]
	Prognostic and Diagnostic Value of Serum Bile Acid Profiles in Pancreatic Cancer: a Retrospective Multicenter Cohort Study. J Gastrointest Cancer Liu C, Qin H, Wu Z, Liu J, Wang M, Yao J, Shang D, Yin P. PMID: 41603998 [PubMed - in process]
	Circulating sPD-L1 as a tumor microenvironment-derived biomarker: enhancing diagnostic discrimination accuracy in breast cancer. Cancer Immunol Immunother Zhang Y, Chen S, Ma J, Sun X, Zhou X. PMID: 41603965 [PubMed - in process]
	[From nontargeted to precision oncology: predictive biomarkers and targeted therapies in advanced urothelial carcinoma]. Urologie Niegisch G, Zschäbitz S, Eckstein M, Klümper N. PMID: 41603912 [PubMed - as supplied by publisher]
	Discussion of DNA Methylation Quantification for Hepatocellular Carcinoma Diagnosis and Prognosis Determination. J Am Coll Surg PMID: 41603786 [PubMed - as supplied by publisher]
	Single-Nucleotide Variation Analysis in Oral Squamous Cell Carcinoma-Related ctDNA by dCas9/sgRNA Recognition-Mediated Proximity Ligation-Triggered Terminal Hairpin Formation and Self-Priming Amplification. Anal Chem Yuan X, Yang F, Chen X, Xiao P, Shen L. PMID: 41603755 [PubMed - as supplied by publisher]
	Becotatug Vedotin in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck: A Multicenter, Phase IIa Trial. Clin Cancer Res Xue L, Han Y, Zhang Q, Li X, Fang M, Zhong L, Wang S, Liu Y, Zhang S, Li Z, Guo Y. PMID: 41603720 [PubMed - as supplied by publisher]
	Real-world efficacy of enfortumab vedotin in Japanese patients with metastatic urothelial carcinoma stratified by EV-301 trial eligibility: a multicenter Bayesian restricted mean survival time analysis. Jpn J Clin Oncol Yajima S, Yoshida S, Chen W, Sato H, Hirakawa A, Fukushima H, Nakamura Y, Tanaka H, Inoue M, Numao N, Yoshinaga A, Kawamura N, Yonese I, Izumi K, Yamamoto T, Uehara S, Suzuki K, Toide M, Takazawa R, Araki S, Masuda H, Fujii Y. PMID: 41603536 [PubMed - as supplied by publisher]
	Anticancer Activity of Picolinamide and Sulfur Chelated Pt(II) Complexes Against Breast Cancer: In Vitro Interaction Studies Through Molecular Docking With Bio-Receptors. Chem Asian J Chatterjee S, Mandal S, Das C, Bhaduri R, Arka Bagchi, Biswas A, Moi SC. PMID: 41603502 [PubMed - in process]
	Photoswitchable Small Molecules for Cancer Therapeutics: Mechanisms, Advances, and Challenges. Chem Asian J Ali S, Tyagi K, Venkatesh V. PMID: 41603482 [PubMed - in process]

Articles 1 - 20 / 1904493

Page 1 of 95225



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy